Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Bactiguard enters agreement with another leading Swedish pharmacy chain

Bactiguard expands its presence in the market for self-care products through a new agreement with another leading Swedish pharmacy chain. The agreement covers both Bactiguard's non-alcoholic disinfection Hydrocyn and a new wound care range."The agreement with Apotek Hjärtat means that our products will be even more accessible, with more channels to choose from. The effective and non-alcoholic Hydrocyn disinfection is already available at apoteket.se, apotea.se and meds.se. The fact that Apotek Hjärtat includes both the disinfection and our new wound care portfolio in its range is an

Report for the first quarter 2021

Financial and operating highlights 1Q21 (1Q20 in brackets): · Operating revenues were NOK 1 338 million (NOK 1 967 million) · EBITDA was NOK 236 million (NOK 250 million) · EBIT was NOK 9 million (NOK -101 million) · Net result after tax was NOK -35 million (NOK 118 million) Post quarter event: · Dividend proposal of NOK 4.00 per share, for the Company NOK 170 million Segment highlights 1Q21 (1Q20 in brackets): Renewable Energy · EBITDA NOK 333 mill. (NOK 419 mill.) · Power generation was lower than normal in Q1 partly offset by higher power prices ·

Attendo's report for the first quarter 2021 shows a split development in Finland and Sweden

Attendo’s report for the first quarter of 2021 shows a two-parted development within the Group. In Finland, occupancy is improving steadily and the operations is showing good underlying organic growth. Occupancy in Sweden is still affected by weak customer inflow related to the pandemic. Overall, sales increased with 1 percent while the reported net operating profit (EBITA) was down SEK 40m compared to the same period last year.Comments from Martin Tivéus, president and CEO “Development in the first quarter was divided. Fortunately, the vaccination program for our customers in care for

Interim Management Statement January – March 2021

First quarter 2021 · Net sales amounted to SEK 202.0 million (182.8), an increase of 10% (excluding foreign exchange effects, 21%). Product sales, net sales excluding royalty revenues, amounted to SEK 196.8 million (177.0), an increase of 11% (excluding foreign exchange effects, 22%). · Net sales in the Paediatrics segment reached SEK 161.6 million (142.5), an increase of 13%. Product sales within Paediatrics amounted to SEK 160.0 million (139.3), an increase of 15%. · Net sales in the Adult Health segment amounted to SEK 38.7 million (40.2), a decrease of 4%. Product sales

AcadeMedia’s interim report July 2020 – March 2021

Third quarter (January – March 2021) · Net sales increased by 9.3 percent and amounted to SEK 3,591 million (3,284). Organic growth, including bolt-on acquisitions and adjusted for currency effects, was 7.3 percent. · Operating profit (EBIT) amounted to SEK 345 million (309). · Adjusted operating profit, adjusted for items affecting comparability and effects of IFRS 16, amounted to SEK 278 million (224). Items affecting comparability amounted to SEK 6 million (36). · Net profit for the period amounted to SEK 190 million (161). · Diluted earnings per share was SEK 1.80 (1.53)

Humana reports first quarter 2021 results

Continued good progressFirst quarter, January–March 2021 · Operating revenue was SEK 1,986m (1,938), an increase of 2%. Organic growth was 2.4%. · Operating profit was SEK 112m (98), an increase of 14%. · Net profit after tax for the period amounted to SEK 63m (53). · Basic and diluted earnings per share for the period amounted to SEK 1.27 (1.00). · Operating cash flow amounted to SEK 197m (95).  Significant events in and after the end of the quarter · In February, Humana acquired the Swedish individual and family company Team J-son. Team J-son’s annual revenue is

Notice of ordinary general meeting DOF ASA

Please find attached the Notice of Ordinary General Meeting DOF ASA. The Ordinary General Meeting will be held on Thursday 27 May 2021 at 11.00 hours, in the company's facilities at Storebø in the municipality of Austevoll. Due to the restrictions caused by COVID-19 and the advice from the Norwegian government in connection therewith, all shareholders are encouraged to exercise their shareholder rights without physical attendance at the general meeting by using the enclosed proxy form. A printed version of the notice will be sent by post to all shareholders. All attachments, in

Tourism Authority of Thailand (TAT), Stockholm Office joins hand with Kastanj Collection to promote the reopening of Thailand for the Nordic countries.

  Tourism Authority of Thailand (TAT), Stockholm Office, has appointed Kastanj Collection to represent TAT for the upcoming “Reopening of Thailand” project for marketing in the Nordic countries (Sweden, Denmark, Norway and Iceland). Kastanj Collection’s mission is to reshape the image of Thailand as an ecofriendly beach destination as well as the touch of the genuine Thailand, to bring Nordic travelers to Thailand, as well as to boost Thailand tourism. The number of arrivals from the Nordic countries to Thailand (before Covid-19) is about 700,000 visitors annually. TAT,

Q1 interim report January – March 2021

Successful bond refinancing extends debt maturity by 5 yearsHighlights first quarter 2021 · Gross collections amounted to EUR 15.7m (22.4)* · Net collections amounted to EUR 13.9 m (19.5)* · Cash EBITDA amounted to EUR 11.2m (17.2)* · Net profit for the period of EUR 0.3m (loss of 0.1)* · Cash at the end of March 2021 was EUR 22.5m (31.4 at December 2020) · Gross ERC at the end of March 2021 was EUR 244m (258 at December 2020) · Assigned a ‘B’ Rating with stable outlook to DDM Debt AB by both S&P Global Ratings and Fitch Ratings Significant events after the end of

Enersense agrees to sell the entire share capital of Värväämö Oy to Citywork

Enersense International PlcInsider information, 6 May 2021 at 9.00 amWith a deed of sale signed today, a provider of zero-emission energy solutions, Enersense International Plc has agreed to sell the entire share capital of its subsidiary Värväämö Oy, which offers personnel services for the construction industry, to Citywork Oy.  Founded in 2006, Citywork is a member of the Celebris Group and provides personnel services in the whole of Finland. Upon completion of the transaction, Citywork is planning to make Värväämö part of its support and personnel services business for the construction

Q1 interim report January – March 2021

Successful bond refinancing extends debt maturity by 5 yearsHighlights first quarter 2021 · Gross collections amounted to EUR 14.4m (22.2)* · Net collections amounted to EUR 12.6m (19.3)* · Cash EBITDA amounted to EUR 10.1m (16.9)* · Net loss for the period of EUR 0.2m (profit of 0.5)* · Cash at the end of March 2021 was EUR 21.6m (30.7 at December 2020) · Assigned a ‘B’ Rating with stable outlook by both S&P Global Ratings and Fitch Ratings Significant events after the end of the quarter · Successfully issued EUR 150m of fixed rate senior secured bonds with a

Lehto Group Plc: Notice to the Annual General Meeting 2021 of Lehto Group Plc

Lehto Group PlcNotice to the Annual General Meeting6 May 2021 at 9:00 a.m. (EET)The shareholders of Lehto Group Plc (the “Company”) are hereby invited to the Annual General Meeting held on Friday 28th of May 2021 at 1 p.m. in Kempele, in the Headquarters of Lehto Group Plc (Voimatie 6 B, 90440 Kempele). The Board of Directors of the Company has resolved to apply exceptional meeting procedures in order to ensure the health and safety of the shareholders and personnel of the Company. Due to the exceptional procedure it is not possible to participate the meeting in the General Meeting

OKEA signs rig frame agreement with COSL Drilling Europe

OKEA ASA has awarded a four-year frame contract to COSL Drilling Europe AS for the use of COSL’s energy-efficient drilling units on the Norwegian Continental Shelf (NCS).As part of the agreement, COSL Drilling Europe (COSL) will be the exclusive provider of semi-submersible drilling rigs for OKEA’s NCS operations, with flexibility in terms of which of COSL’s identical and energy-efficient rigs are to be used. The agreement has four one-year extension options giving a potential total contract length of eight years. ‘OKEA expects to take a number of drill decisions in the coming months and

Veidekke ASA: Adopts ambition to reach climate neutrality by 2045

Climate is central to Veidekke's strategy, as will be announced at the group’s capital markets update today. In light of the updated strategy, Veidekke has resolved to raise its climate ambition, aiming to achieve climate neutrality by 2045. The ambition involves cutting greenhouse gas emissions from Veidekke’s own operations and its value chain to net zero before 2045, in line with an emissions pathway of limiting global warming to 1.5[o]C.“Veidekke plans to take on an active role in realising the Green Shift, and will consecutively seek opportunities to reduce greenhouse gas emissions in

Interim Report January–March 2021

John Mattson established in four municipalitiesIn the space of one year, John Mattson has established operations in another three municipalities in the Stockholm region and now has, in addition to Lidingö, operations in Sollentuna, Stockholm and Nacka. “We look forward to developing partnerships and continuing to grow in these municipalities and in the region in general. The ambition is to acquire new builds, older residential properties and development rights in locations with good development opportunities and easy access to transportation,” says Siv Malmgren, CEO of John Mattson.

Polygiene (publ.) Interim Report 1 January–31 March 2021

Strong quarter shows the strength of the new Polygiene GroupQ1 IN BRIEF (JANUARY – MARCH 2021) · Net sales amounted to MSEK 42.0 during the first quarter and a positive growth by 141.4 % compared to the same period last year · The operating profit/loss EBIT amounted to MSEK 10.3 (0.2) · The gross margin amounted to 64.8 (67.2) % · The cash flow is improved compared to the same quarter last year, MSEK 31.0 (2.2) EVENTS DURING FIRST QUARTER (JANUARY – MARCH 2021) · Polygiene’s subsidiary Addmaster and CAT® launches the first fully antimicrobial mobile phone ·

BONESUPPORT Holding AB (publ) – Publishes Q1 2021 Interim report

Lund, Sweden, 08:00 CET, May 6 2021 – BONESUPPORT Holding AB (publ), an emerging leader in orthobiologics for the management of bone injuries, today publishes the interim report for the first quarter 2021. FEWER SURGERIES IN THE WAKE OF AN INTENSIFIED PANDEMIC   JANUARY - MARCH 2021 · Net sales increased by 3 percent (14 percent at constant exchange rates) and amounted to SEK 44.8 million (43.4). · The North America (NA) segment reported a sales increase of 18 percent (36 percent at constant exchange rate). · The Europe & Rest of the World (EUROW) segment reported a

LeoVegas AB Q1: Quarterly report 1 January - 31 March 2021

“A good start to the year and increased focus on sports”Gustaf Hagman, Group CEO first quarter 2021: 1 january–31 march         · Revenue increased by 8% to EUR 96.7 m (89.4). Organic growth in local currencies was 8%. · Organic growth when excluding Germany was 19%. · Adjusted EBITDA was EUR 10.9 m (9.0), corresponding to an adjusted EBITDA margin of 11.3% (10.0%). Reported EBITDA was EUR 10.4 m (9.0). · The number of depositing customers was 462,386 (413,269), an increase of 12%. · Adjusted earnings per share were EUR 0.07 (0.06). events during the quarter ·

Interim report January-March 2021

ON THE WAY TO A STRONGER SERNEKEJanuary-March 2021 · Order bookings amounted to SEK 1,179 million (2,975) and the order backlog was SEK 13,126 million (10,576) · Revenue amounted to SEK 1,950 million (1,814) · Operating profit amounted to SEK 31 million (loss: 149) · Cash flow from operating activities amounted to an outflow of SEK 2 million (233) · Profit for the period amounted to SEK 46 million (loss: 106) · At the end of the period, available cash and cash equivalents amounted to SEK 704 million (646) · The equity/assets ratio was 36.2 percent (37.0) · On

Lipidor publishes interim report for Q1 2021

STOCKHOLM, Sweden, 6 May 2021: Today, Lipidor AB (publ) (Nasdaq First North: LIPI) publishes its interim report for the period January – March 2021. The quarterly report is available on the company's website (click here ) and in the attached pdf (in Swedish).Summary of the interim report – first quarter 2021 The period began with a signed license agreement with Cannassure Therapuetics Ltd, regarding medical cannabis products based on Lipidor's AKVANO® technology. Activities prior to the start of the Phase III study with AKP02, and

Optomed Plc: Interim Report, January – March 2021

Optomed Plc           Stock Exchange Release         6 May 2021 at 9:00, Helsinki Optomed Plc: Interim Report, January – March 2021 January – March 2021 · Revenue increased by 30.0 percent to EUR 3,944 (3,034) thousand. At comparable exchange rates, revenue grew by 30.4% · Devices segment revenue increased by 48.6 % to EUR 1,447 (974) thousand. At comparable exchange rates, the segment revenue grew by 49.9% · Software segment revenue increased by 21.2 % to EUR 2,497 (2,060) thousand · EBITDA amounted to EUR –315 (-575) thousand corresponding to –8.0 (-19.0) percent of

Citycon Q1/2021: Quarter over quarter growth

CITYCON OYJ   Interim Report   6 May 2021 at 09:00 hrs- NRI EUR 50.4 million -3.8% compared to Q1/2020: an improvement over the previous quarter- Total tenant sales at -4.7% y-o-y- Administrative expenses improved -13% y-o-y due to tight cost control- Direct operating profit EUR 44.9 million (-2.9%) reflecting NRI development- Slightly positive valuations supported by positive leasing momentum- Divestment of 3 non-core assets as a part of planned capital recycling and portfolio transformation- LTV lowered to 46.5% as a result of the divestment- Successful issue of EUR 350

Outokumpu interim report January–March 2021: Strong start to the year – adjusted EBITDA increased to EUR 177 million

Outokumpu OyjInterim reportMay 6, 2021 at 9.00 am EESTOutokumpu interim report January–March 2021: Strong start to the year – adjusted EBITDA increased to EUR 177 million  Highlights in January–March 2021 · Stainless steel deliveries were 608,000 tonnes (Q1/2020: 588,000 tonnes)[1]. · Adjusted EBITDA was EUR 177 million (EUR 106 million). · EBITDA was EUR 177 million (EUR 106 million). · Operating cash flow was EUR 27 million (EUR -32 million). · Net debt was EUR 1,073 million (December 31, 2020: EUR 1,028 million). · Gearing was 43.7% (December 31, 2020: 43.6%).

Karo Pharma to sell its treasury shares

Karo Pharma (“Karo”) pursues a growth strategy, which combines geographical expansion with an active acquisition strategy. To execute on this strategy, Karo needs capital and a strong financial position. The treasury shares represent an unutilized resource in the company and a sale of the shares enhances Karo’s financial flexibility. On October 30, 2020 Karo communicated its intentions to sell its treasury shares for the above purpose. This process has now been completed and Karo today announces the sale of all remaining (1,375,417) treasury shares, representing approximately 0.6% of the

There are no items matching the current filter
There are no more items matching the current filter
Back to top